尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Proxy Form for 2019 Annual General Meeting
2020-05-13
Reply Slip for Annual General Meeting for the Year 2019
2020-05-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2020-05-06
Annual Report 2019
2020-04-27
2019 Corporate Social Responsibility Report
2020-04-21
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION, THE RULES AND PROCEDURES FOR
2020-04-21
Overseas Regulatory Announcement
2020-04-21
Overseas Regulatory Announcement
2020-04-21
UNAUDITED FIRST QUARTER RESULTS OF 2020
2020-04-21
Acquisition of 27% of equity interest in Shandong Xinhua Wanbo Chemical Industri
2020-04-20
<
...
38
39
40
41
42
43
44
...
>